Company / Revenue per Share
Harmony Biosciences Holdings, Inc. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.20
FY2025
5-year range
$0.11 / $15.20
FY2021-FY2025
Trend
+20.7%
vs FY2024
Sector context
#33 of 154
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s revenue per share of $15.20 is higher than 79% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 4 consecutive years, from $0.11 in FY2021 to $15.20 in FY2025.
Based on SEC 10-K filings.
15.20 in FY2025 with a 5-year CAGR of +81.6%. Top quartile in the Health Care sector.
Improved from $9.76 to $15.20 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +26.9%
- 5-Year CAGR
- +81.6%
- 10-Year CAGR
- -
Sector benchmark
+46.8% above sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 20.7% year-over-year.
- Ranks #33 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.20 | +20.7% |
| FY2024 | $12.59 | +29.0% |
| FY2023 | $9.76 | +31.2% |
| FY2022 | $7.44 | +6963.4% |
| FY2021 | $0.11 | -86.3% |
| FY2020 | $0.77 | -0.1% |
| FY2019 | $0.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026